Lipid Nanoparticle-based delivery of peptide-based therapeutic agents to anaplastic thyroid cancer

Authors

Institutions

Publication Details

Journal
ORBi UMONS
Published
2025-10-23
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lipid Nanoparticle-based delivery of peptide-based therapeutic agents to anaplastic thyroid cancer

Thomas Vangijzegem, Sven Saussez, Juliette Ninane, Dimitri Stanicki et al.
ORBi UMONS
Nanoparticle-Based Drug Delivery
article

Lipid Nanoparticle-based delivery of peptide-based therapeutic agents to anaplastic thyroid cancer

Thomas Vangijzegem, Sven Saussez, Juliette Ninane, Dimitri Stanicki, Carmen Burtea, Zehra Cagla Kahvecioglu, Rachel Baillif, Sophie Laurent, Chloé Millaire, Nilay Yesilbas
article en

Abstract

No abstract available for this paper.
ORBi UMONS
University of Mons (BE), Laboratoire de Chimie Organique (FR)
Good health and well-being
Openalex Percentile: Top 38%
Nanoparticle-Based Drug Delivery
Open Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lipid Nanoparticle-based delivery of peptide-based therapeutic agents to anaplastic thyroid cancer — Thomas Vangijzegem, Sven Saussez, et al. · ORBi UMONS (2025) | TGRS Research Map | TGRS